Blood Banking Innovations Supporting Blood Transfusion Market Development
Author : researcher marketing | Published On : 28 May 2026
The global blood transfusion market is witnessing steady growth due to the increasing prevalence of chronic diseases, rising number of surgical procedures, growing trauma cases, and advancements in blood collection and storage technologies. Healthcare institutions across developed and emerging economies are increasingly focusing on improving blood management systems, transfusion safety, and donor awareness programs to support rising patient demand.
The global blood transfusion market size was valued at USD 7.1 Billion in 2024 and is projected to grow from USD 7.53 Billion in 2025 to reach USD 12 Billion by 2033, exhibiting a CAGR of 6% during the forecast period (2025–2033).
Key Highlights
- North America dominated the global blood transfusion market and accounted for the largest market share.
- Asia-Pacific is expected to be the fastest-growing region during the forecast period.
- By product type, blood components held the largest market share.
- By application, anemia treatment accounted for the largest market share.
- By end-user, hospitals represented the leading segment in the global market.
- Increasing demand for emergency care and trauma management is driving market expansion globally.
- Technological advancements in blood screening and storage systems are enhancing transfusion safety and efficiency.
Market Dynamics
Market Drivers
The growing incidence of chronic diseases such as cancer, kidney disorders, cardiovascular diseases, and blood-related disorders is significantly increasing the demand for blood transfusion procedures worldwide. Patients undergoing chemotherapy, organ transplants, and complex surgeries frequently require blood and blood components, creating sustained demand across hospitals and healthcare facilities. Additionally, the rising number of road accidents, trauma injuries, and emergency medical procedures continues to support market growth.
Another major driver is the increasing focus on improving healthcare infrastructure and blood donation awareness programs globally. Governments, healthcare organizations, and non-profit institutions are actively promoting voluntary blood donation campaigns to maintain adequate blood supply levels. Advancements in blood screening technologies, automated blood collection systems, and safer transfusion practices are also improving operational efficiency and patient outcomes.
Market Restraints
Despite favorable growth trends, the blood transfusion market faces challenges associated with blood storage limitations, risk of transfusion-transmitted infections, and stringent regulatory requirements. Maintaining the safety, quality, and shelf life of blood products requires sophisticated infrastructure and continuous monitoring, which can increase operational costs for healthcare facilities and blood banks.
In addition, inadequate blood donation rates in certain developing regions and concerns regarding compatibility and adverse transfusion reactions may hinder market growth. Limited healthcare access and insufficient blood banking infrastructure in underdeveloped economies continue to create supply-demand gaps.
Market Opportunities
The increasing adoption of advanced blood management systems and digital healthcare technologies is expected to create significant growth opportunities in the market. Automation in blood collection, testing, storage, and distribution processes is improving traceability and reducing human errors in transfusion procedures.
Emerging economies also present strong growth potential due to expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness regarding blood donation and transfusion safety. Rising investments in plasma fractionation technologies and research activities related to synthetic blood substitutes are further expected to support long-term market expansion.
Top Market Players
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Cerus Corporation
- CSL Limited
- Fresenius Kabi AG
- Grifols S.A.
- Haemonetics Corporation
- Macopharma
- Terumo Corporation
Market Segmentation
By Product Type
- Whole Blood
- Blood Components
- Red Blood Cells
- Platelets
- Plasma
- Others
By Application
- Anemia
- Surgery
- Trauma and Accidents
- Cancer Treatment
- Blood Disorders
- Others
By End-User
- Hospitals
- Blood Banks
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Regional Analysis
North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/blood-transfusion-market
About Us
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.
Contact Us
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
